World Menopause Day 2023
Interview
Podcast
World Menopause Day 2022
Interviews
Podcasts
World Menopause Day 2021
Interviews
Podcasts
Interviews
Videos
Podcasts
World Congresses
16th World Congress (2018), Vancouver, Canada
How to assess breast cancer risk and which menopause treatment for which patient? – Meet the Experts
16th IMS World Congress – The IMPART Project
“Testosterone for FSIAD – ‘Yeh or Nay’?” – a Debate
Optimising HRT for Cardiovascular Health – Meet the Experts
TSEC’s, delivering estrogen while blocking dangerous side effects
Transdermal MHT key issues – 16 years post WHI.
16th IMS World Congress – Nick Panay
16th IMS World Congress – Mary Ann Lumsden
Breaking News – “Vit D – the controversy continues”
Optimizing the Pelvic Floor – a Symposium by John DeLancey.
Cardiovascular window of opportunity – IMS Symposium
Contraception for the older woman – IMS Symposium
Androgens – too much or too little? – Symposium
Current status of ovarian stem cells – Richard Anderson – Plenary Lecture
Hormone Therapy and breast cancer: risk communication and the perfect storm – Robert Reid – Plenary lecture
Preventive strategies for osteoporosis – an IMS Symposium
Future Research Directions – How to get your research published – an IMS symposium
Advances in Endometriosis – an IMS Symposium
Meet the Experts – Starting and Stopping HRT – How to do it safely
The multifaceted aspects of female sexual function
Treatment strategies for urogenital atrophy
In-depth investigation of discontinuing hormone therapy
Vasomotor symptoms: an important marker of ongoing health for perimenopausal women
Prof. Mary Ann Lumsden – Disease prevention strategies
Tommaso Simoncini – Pelvic floor disorders and menopause
World Menopause Day
World Menopause Day 2017
Perimenopausal Bleeding
Steve Goldstein
Regional Congresses
Belgrade – Nov-17
Bioidentical hormone therapy – where are we now?
Nick Panay Q and A
Managing Menopause with endometriosis
The benefits of transdermal menopausal hormone therapy
Elaine Jolly Q and A
SERM: from Tamoxifen to TSECs – Q and A
SERM: from Tamoxifen to TSECs
Vasomotor symptoms
Vasomotor symptoms Q and A
Climacteric symptoms after breast cancer
Hormone therapy and sexual function in women age 55-85
Managing menopausal women with androgen excess
Androgen insufficiency and replacement
Sexual desire disorder
IMS Webinars
1st Series – 2015 (For current series, click here)
